[Skip to Content]
[Skip to Content Landing]
Views 4,078
Citations 0
Viewpoint
August 12, 2019

A Professional Standard for Informed Consent for Stem Cell Therapies

Author Affiliations
  • 1Berman Institute of Bioethics, Johns Hopkins University School of Medicine, Baltimore, Maryland
  • 2Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland
  • 3WT-MRC Cambridge Stem Cell Institute, Department of Clinical Neuroscience, University of Cambridge, Cambridge, England
  • 4University of Wisconsin Law School, Madison
  • 5Stanford Center for Advanced Studies in Behavioral Sciences, Stanford University, Palo Alto, California
JAMA. Published online August 12, 2019. doi:10.1001/jama.2019.11290

In November 2018, the US Food and Drug Administration (FDA) issued a press release that stated: “The potential health benefits of regenerative medicine have spurred major progress in stem-cell biology over the past several decades. But we continue to see bad actors exploit the scientific promise of this field to mislead vulnerable patients into believing they’re being given safe, effective treatments; when instead these stem cell producers are leveraging the field’s hype to push unapproved, unproven, illegal, and potentially unsafe products.”1

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    ×